Erratum: Sema3E - Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice (The Journal of Clinical Investigation (2010) 120, 8, (2684-26980) DOI: 10.1172/JCI42118);Sema3E-Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice

Journal of Clinical Investigation

Volumn 120, Issue 8, 2010, Pages 2684-2698

  Casazza, Andrea ^a   Finisguerra, Veronica ^b,c   Capparuccia, Lorena ^a   Camperi, Andrea ^a   Swiercz, Jakub M ^d   Rizzolio, Sabrina ^a   Rolny, Charlotte ^a,g   Christensen, Claus ^e   Bertotti, Andrea ^a   Sarotto, Ivana ^a   Risio, Mauro ^a   Trusolino, Livio ^a   Weitz, Jurgen ^f   Schneider, Martin ^f   Mazzone, Massimilano ^b,c   Comoglio, Paolo M ^a   Tamagnone, Luca ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d MAX PLANCK INSTITUTE FOR HEART AND LUNG RESEARCH   (Germany)

^e DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^f UNIVERSITY OF HEIDELBERG   (Germany)

^g UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; PLEXIN; PLEXIN D1; SEMAPHORIN; SEMAPHORIN 3E; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INVASION; CARCINOMA CELL; CELL STRAIN COS1; CELL STRAIN HCT116; COLON CARCINOMA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSACTIVATION;

EID: 77955286842     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI59033     Document Type: Erratum

References (39)

1. Zhou Y, Gunput RA, Pasterkamp RJ. Semaphorin signaling: progress made and promises ahead. Trends Biochem Sci. 2008;33(4):161-170.
2. Tamagnone L, Comoglio PM. Signalling by semaphorin receptors: cell guidance and beyond. Trends Cell Biol. 2000;10(9):377-383.
3. Casazza A, Fazzari P, Tamagnone L. Semaphorin signals in cell adhesion and cell migration: functional role and molecular mechanisms. Adv Exp Med Biol. 2007;600:90-108.
4. Giordano S, et al. The semaphorin 4D receptor controls invasive growth by coupling with Met. Nat Cell Biol. 2002;4(9):720-724.
5. Toyofuku T, et al. Dual roles of Sema6D in cardiac morphogenesis through region-specific association of its receptor, Plexin-A1, with off-track and vascular endothelial growth factor receptor type 2. Genes Dev. 2004;18(4):435-447.
6. Swiercz JM, Kuner R, Offermanns S. Plexin-B1/RhoGEF-mediated RhoA activation involves the receptor tyrosine kinase ErbB-2. J Cell Biol. 2004;165(6):869-880.
7. Swiercz JM, Worzfeld T, Offermanns S. ErbB-2 and Met reciprocally regulate cellular signaling via Plexin-B1. J Biol Chem. 2008;283(4):1893-1901.
8. Franco M, Tamagnone L. Tyrosine phosphorylation in semaphorin signalling: shifting into over-drive. EMBO Rep. 2008;9(9):865-871.
9. Neufeld G, Kessler O. The semaphorins: versatile regulators of tumour progression and tumour angiogenesis. Nat Rev Cancer. 2008;8(8):632-645.
10. Capparuccia L, Tamagnone L. Semaphorin signaling in cancer cells and in cells of the tumor microenvironment - two sides of a coin. J Cell Sci. 2009;122(pt 11):1723-1736.
11. Castro-Rivera E, Ran S, Thorpe P, Minna JD. Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effect. Proc Natl Acad Sci U S A. 2004;101(31):11432-11437.
12. Rolny C, et al. The tumor suppressor semaphorin 3B triggers a prometastatic program mediated by interleukin 8 and the tumor microenvironment. J Exp Med. 2008;205(5):1155-1171.
13. Bielenberg DR, et al. Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype. J Clin Invest. 2004;114(9):1260-1271.
14. Kessler O, et al. Semaphorin-3F is an inhibitor of tumor angiogenesis. Cancer Res. 2004;64(3):1008-1015.
15. Basile JR, Castilho RM, Williams VP, Gutkind JS. Semaphorin 4D provides a link between axon guidance processes and tumor-induced angiogenesis. Proc Natl Acad Sci U S A. 2006;103(24):9017-9022.
16. Sierra JR, et al. Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages. J Exp Med. 2008;205(7):1673- 1685.
17. Christensen CR, Klingelhöfer J, Tarabykina S, Hulgaard EF, Kramerov D, Lukanidin E. Transcription of a novel mouse semaphorin gene, M-semaH, correlates with the metastatic ability of mouse tumor cell lines. Cancer Res. 1998;58(6):1238-1244.
18. Martín-Satué M, Blanco J. Identification of semaphorin E gene expression in metastatic human lung adenocarcinoma cells by mRNA differential display. J Surg Oncol. 1999;72(1):18-23.
19. Christensen C, et al. Proteolytic processing converts the repelling signal Sema3E into an inducer of invasive growth and lung metastasis. Cancer Res. 2005;65(14):6167-6177.
20. Gu C, et al. Semaphorin 3E and plexin-D1 control vascular pattern independently of neuropilins. Science. 2005;307(5707):265-268.
21. Gitler AD, Lu MM, Epstein JA. PlexinD1 and semaphorin signaling are required in endothelial cells for cardiovascular development. Dev Cell. 2004;7(1):107-116.
22. Moriya J, et al. Inhibition of semaphorin as a novel strategy for therapeutic angiogenesis. Circ Res. 2010;106(2):391-398.
23. Roodink I, et al. Plexin D1 expression is induced on tumor vasculature and tumor cells: a novel target for diagnosis and therapy? Cancer Res. 2005;65(18):8317-8323.
24. Roodink I, Verrijp K, Raats J, Leenders WP. Plexin D1 is ubiquitously expressed on tumor vessels and tumor cells in solid malignancies. BMC Cancer. 2009;9:297.
25. Uesugi K, Oinuma I, Katoh H, Negishi M. Different Requirement for Rnd GTPases of R-Ras GAP Activity of Plexin-C1 and Plexin-D1. J Biol Chem. 2009;284(11):6743-6751.
26. Chauvet S, et al. Gating of Sema3E/PlexinD1 signaling by neuropilin-1 switches axonal repulsion to attraction during brain development. Neuron. 2007;56(5):807-822.
27. Kigel B, Varshavsky A, Kessler O, Neufeld G. Successful inhibition of tumor development by specific class-3 semaphorins is associated with expression of appropriate semaphorin receptors by tumor cells. PLoS ONE. 2008;3(9):e3287.
28. Roodink I, et al. Semaphorin 3E expression correlates inversely with Plexin D1 during tumor progression. Am J Pathol. 2008;173(6):1873-1881.
29. Yilmaz M, Christofori G. EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev. 2009;28(1-2):15-33.
30. Yarden Y, Sliwkowski MX. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol. 2001;2(2):127-137.
31. Feldner JC, Brandt BH. Cancer cell motility - on the road from c-erbB-2 receptor steered signaling to actin reorganization. Exp Cell Res. 2002;272(2):93-108.
32. Hirsch FR, Varella-Garcia M, Cappuzzo F. Predictive value of EGFR and HER2 overexpression in advanced non-small-cell lung cancer. Oncogene. 2009;28(suppl 1):S32-S37.
33. Kopfstein L, Christofori G. Metastasis: cell autonomous mechanisms versus contributions by the tumor microenvironment. Cell Mol Life Sci. 2006;63(4):449-468.
34. Kotliarov Y, et al. High-resolution global genomic survey of 178 gliomas reveals novel regions of copy number alteration and allelic imbalances. Cancer Res. 2006;66(19):9428-9436.
35. Sanchez-Carbayo M, Socci ND, Lozano J, Saint F, Cordon-Cardo C. Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays. J Clin Oncol. 2006;24(5):778-789.
36. Talantov D, et al. Novel genes associated with malignant melanoma but not benign melanocytic lesions. Clin Cancer Res. 2005;11(20):7234-7242.
37. Hoek KS, et al. Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature. Pigment Cell Res. 2006;19(4):290-302.
38. Follenzi A, Naldini L. Generation of HIV-1 derived lentiviral vectors. Methods Enzymol. 2002;346:454-465.
39. Barberis D, et al. Plexin signaling hampers integrin-based adhesion, leading to Rho-kinase independent cell rounding, and inhibiting lamellipodia extension and cell motility. FASEB J. 2005;18(3):592-594.